PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, July 9, 2009: CPST, FACT, MDSO, IXYS, PAET and SPLS.
Jul 09, 2009 (M2 PRESSWIRE via COMTEX) --
Companies: Capstone Turbine Corporation (CPST), Facet Biotech Corp (2811565Z), First Albany Companies, Inc. (FACT), IXYS Corp. (IXYS), Medidata Solutions Inc (MDSO), PAETEC Holding Corp (PAET), Staples, Inc. (SPLS)
Picksthatmove.com Alerts include Capstone Turbine Corporation (Nasdaq: CPST); Facet Biotech Corporation (NASDAQ: FACT); Medidata Solutions (NASDAQ: MDSO); IXYS Corporation (NASDAQ: IXYS); PAETEC Holding Corp. (NASDAQ GS: PAET) and Staples, Inc. (Nasdaq: SPLS)
-- July 8, 2009 Capstone Turbine Corporation (Nasdaq:CPST) closed at $0.75 on a volume of 1,893,075 shares.
In a press release out on July 9, 2009 Capstone Turbine Expands Presence in South America -- Names Supernova Energy Services Its Distributor in Colombia
CHATSWORTH, Calif., Jul 9, 2009 -- Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world's leading clean technology manufacturer of microturbine energy systems, today announced it named Supernova Energy Services as its distributor in Colombia.
About Capstone Turbine Corporation
Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST) is the world's leading producer of low-emission microturbine systems, and was the first to market commercially viable microturbine energy products. Capstone Turbine has shipped over 4,000 Capstone MicroTurbine(R) systems to customers worldwide. These award-winning systems have logged millions of documented runtime operating hours. Capstone Turbine is a member of the U.S. Environmental Protection Agency's Combined Heat and Power Partnership, which is committed to improving the efficiency of the nation's energy infrastructure and reducing emissions of pollutants and greenhouse gases. A UL-Certified ISO 9001:2000 and ISO 14001:2004 certified company; Capstone is headquartered in the Los Angeles area with sales and/or service centers in the New York metro area, Mexico City, Nottingham, Shanghai, Singapore and Tokyo.
-- July 8, 2009 Facet Biotech Corporation (NASDAQ: FACT) closed at $7.76 on a volume of 169,671 shares.
In a press release out on July 9, 2009 Facet Biotech Appoints Mark Rolfe, Ph.D. as Senior Vice President and Chief Scientific Officer
REDWOOD CITY, CA, Jul 09, 2009 -- Facet Biotech Corporation (NASDAQ: FACT) today announced the appointment of Mark Rolfe, Ph.D., as Senior Vice President and Chief Scientific Officer. Dr. Rolfe will be responsible for leading the company's research efforts, including target validation, translational medicine and protein engineering technologies. He will join the company on August 20, 2009.
About Facet Biotech
Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products and leveraging its research and development capabilities to identify and develop new oncology drugs. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.
-- July 8, 2009 Medidata Solutions (NASDAQ: MDSO) closed at $15.80 on a volume of 852,833 shares.
In a press release out on July 9, 2009 EPS Expands EDC Services Through Medidata Solutions Accreditation
First Asia-based CRO to Achieve Medidata's Highest ASPire to Win Accreditation
NEW YORK and TOKYO, Jul 09, 2009 -- Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that EPS is the first Asia-based contract research organization (CRO) to reach Rave Accredited Plus, the most advanced level in Medidata's ASPire to Win(R) program for CROs and other service providers. The accreditation enables EPS, headquartered in Tokyo, to serve as a one-stop shop of Medidata Rave(R) implementation services for sponsors conducting clinical trials in Asia. EPS has invested in the Rave training of data management teams in both Japan and China, positioning itself to serve sponsors across Asia.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer(TM)), investigator benchmarking and budgeting (Medidata Grants Manager(TM)), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor(TM)), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave(R)). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies
-- July 8, 2009 IXYS Corporation (NASDAQ:IXYS) closed at $8.88 on a volume of 115,627 shares.
In a press release out on July 9, 2009 Clare Announces New Eight-Channel High Voltage Analog Switch IC
New CPC7232 Eight-Channel High Voltage Analog Switch IC Targeted for Ultrasound Applications
BEVERLY, Mass., Jul 09, 2009 -- Clare, Inc., a wholly owned subsidiary of IXYS Corporation (NASDAQ:IXYS) announces the immediate availability of the CPC7232, an eight-channel high voltage analog switch IC. Designed using Clare's proprietary high voltage BCDMOS on SOI (silicon on insulator) process, the CPC7232 combines high voltage, bilateral DMOS switches with low power CMOS logic. This results in the efficient control of high voltage analog signals with low voltage logic control signals. The CPC7232 is ideal for medical ultrasound imaging, test equipment, printers, and industrial measurement applications.
About Clare and IXYS Corporation
Clare, Inc., a leader in the design and manufacture of solid-state relays and high voltage integrated circuits, is a wholly owned subsidiary of IXYS Corporation. IXYS Corporation develops and markets primarily high performance power semiconductor devices that are used in controlling and converting electrical power efficiently in power systems for the telecommunication internet infrastructure, motor drives, medical systems, Solar energy, Wind energy, electrical generators and transportation. IXYS also serves its markets with a combination of digital and analog integrated circuits, RF power products and power subsystems. Additional information about Clare and IXYS may be found at www.clare.com andwww.ixys.com, or by sending an email to info@clare.com.
-- July 8, 2009 PAETEC Holding Corp. (NASDAQ GS: PAET) closed at $2.58 on a volume of 385,882 shares.
In a press release out on July 9, 2009 PAETEC Commends FCC Adoption of Procedural Rules on Forbearance Petitions
New Rules, which were proposed by PAETEC and others, will promote broadband competition
FAIRPORT, N.Y., Jul 09, 2009 -- PAETEC Holding Corp. (NASDAQ GS: PAET) expresses appreciation to the Federal Communications Commission ("FCC") for adoption of procedural rules on forbearance petitions which will promote fairness and lead to more informed decision-making. The new rules are a welcome change at the FCC. "Ensuring a regulatory structure that promotes a competitive telecommunications environment will benefit businesses through availability of new communication technologies and improved services at a better value and assist in the economic recovery," said PAETEC Vice President of Public Policy & Regulatory, William A. Haas.
About PAETEC
PAETEC (NASDAQ: PAET) is personalizing business communications for medium and large businesses, enterprise organizations and institutions across the United States. We offer a comprehensive suite of IP, voice, data, and Internet services, as well as enterprise communications management software, network security solutions, CPE, and managed services. For more information, visit www.paetec.com.
-- July 8, 2009 Staples, Inc. (Nasdaq: SPLS) closed at $19.38 on a volume of 9,759,124 shares
In a press release out on July 9, 2009 Staples, Inc. Appoints Amee Chande Senior Vice President of Strategy
FRAMINGHAM, Mass., Jul 09, 2009 -- Staples, Inc. (Nasdaq: SPLS) today announced the appointment of Amee Chande as senior vice president of strategy, responsible for working with senior management to develop all elements of the company's global strategy. Chande reports to John Mahoney, Staples vice chairman and chief financial officer.
About Staples
Staples, the world's largest office products company, is committed to making it easy for customers to buy a wide range of office products, including supplies, technology, furniture, and business services. With 2008 sales of $23 billion and 91,000 associates worldwide, Staples serves businesses of all sizes and consumers in 27 countries throughout North and South America, Europe, Asia and Australia. In July 2008, Staples acquired Corporate Express, one of the world's leading suppliers of office products to businesses and institutions. Staples invented the office superstore concept in 1986 and is headquartered outside Boston. More information about Staples (Nasdaq: SPLS) is available at www.staples.com.
About PicksThatMove.com
www.picksthatmove.com team of excellence strives to find undervalued, good momentum stock plays. We provide financial and investor relations services for small to mid-cap stocks with weekly and special newsletters to keep you informed of the latest movers. Unlike other sites, we explore, research, and understand all aspects of a company. We only recommend companies we feel has the potential for future higher valuations. Our seasoned research team is always looking for the next Xtreme Pick to send to you.
www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com
www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: PicksThatMove.com e-mail: Info@picksthatmove.com WWW: http://www.picksthatmove.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
Copyright (C) 2009 M2. All rights reserved
News Provided by COMTEX
Companies: Capstone Turbine Corporation (CPST), Facet Biotech Corp (2811565Z), First Albany Companies, Inc. (FACT), IXYS Corp. (IXYS), Medidata Solutions Inc (MDSO), PAETEC Holding Corp (PAET), Staples, Inc. (SPLS)
Related terms: academic, adoption, advisor, asia, australia, bandwidth, biotechnology, broker, business, business services, california, china, clinical, colombia, communications, contract, contractor, corporate, dealer, distributor, drugs, electrical, email, e-mail, energy, engineering, environment, environmental protection agency, eps, europe, grants, industrial, internet, investment, japan, knowledge management, manufacturer, market, medical, medicine, mexico, nasdaq, new york, pharmaceuticals, pipeline, president, products, profit, public policy, research, research and development, sales, security, shanghai, singapore, small cap, software, solar power, south america, technology, telecommunications, tokyo, training, transportation, trial, web, wind power
